Tseng et al., also demonstrated that CIP2A mediates bortezomib-induced apoptosis also in TNBC [111] which is in line with their previous reports that CIP2A mediated effects of bortezomib on pAKT and apoptosis in hepatocellular carcinoma. This evidence concerns the gene CIP2A and hepatocellular carcinoma.